UB Paderborn / Katalog / Suche / in CDI

Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

The New England journal of medicine, 2011-08, Vol.365 (8), p.699-708

2011

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis of tuberculosis in the wild boar (Sus scrofa): a comparison of methods applicable to hunter-harvested animals

PloS one, 2010-09, Vol.5 (9), p.e12663

2010

Link zum Volltext

Verfügbarkeit prüfen

QT/QTc Prolongation in Placebo-Treated Subjects: a PhRMA Collaborative Data Analysis

Journal of biopharmaceutical statistics, 2008-05, Vol.18 (3), p.408-426

2008

Link zum Volltext

Verfügbarkeit prüfen

Alternative Analysis Methods for Time to Event Endpoints Under Nonproportional Hazards: A Comparative Analysis

Statistics in biopharmaceutical research, 2020-04, Vol.12 (2), p.187-198

2020

Link zum Volltext

Verfügbarkeit prüfen

Diversity and composition of cultivable gut bacteria in an endemic island bird and its mainland sister species

Symbiosis (Philadelphia, Pa.), 2017-02, Vol.71 (2), p.155-164

2017

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial susceptibility and oxymino-β-lactam resistance mechanisms in Salmonella enterica and Escherichia coli isolates from different animal sources

Research in microbiology, 2015-09, Vol.166 (7), p.574-583

2015

Link zum Volltext

Verfügbarkeit prüfen

JAVELIN head and neck 100: A phase 3 trial of avelumab in combination with chemoradiotherapy (CRT) vs CRT for 1st-line treatment of locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS6093-TPS6093

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparative Genotypic and Antimicrobial Susceptibility Analysis of Zoonotic Campylobacter Species Isolated from Broilers in a Nationwide Survey, Portugal

Journal of food protection, 2012-12, Vol.75 (12), p.2100-2109

2012

Link zum Volltext

Verfügbarkeit prüfen

Ceritinib in advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK+) non-small cell lung cancer (NSCLC): Results of the ASCEND-1 trial

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.8003-8003

2014

Link zum Volltext

Verfügbarkeit prüfen

Ceritinib in Asian versus Caucasian patients (Pts) with advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK+) NSCLC: Subgroup analysis of the ASCEND-1 trial

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.8078-8078

2014

Link zum Volltext

Verfügbarkeit prüfen

BM-32 CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v39-v39

2014

Link zum Volltext

Verfügbarkeit prüfen

BM-32CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v39-v39

2014

Link zum Volltext

Verfügbarkeit prüfen

Apixabin with antiplatelet therapy after acute coronary syndrome

The New England journal of medicine, 2011-08, Vol.365 (8), p.699

2011

Link zum Volltext

Verfügbarkeit prüfen

Investigating Drug-Induced QT and QTc Prolongation in the Clinic: A Review of Statistical Design and Analysis Considerations: Report from the Pharmaceutical Research and Manufacturers of America QT Statistics Expert Team

Therapeutic innovation & regulatory science, 2005-07, Vol.39 (3), p.243-265

Patterson, Scott D.

2005

Link zum Volltext

Verfügbarkeit prüfen

An adaptive randomized design with application to estimation

Canadian journal of statistics, 2001-03, Vol.29 (1), p.107-116

2001

Link zum Volltext

Verfügbarkeit prüfen

The doubly adaptive weighted differences design

Journal of statistical planning and inference, 2006-06, Vol.136 (6), p.1923-1939

2006

Link zum Volltext

Verfügbarkeit prüfen

A biocompatible redox MRI probe based on a Mn(ii)/Mn(iii) porphyrin

Dalton transactions : an international journal of inorganic chemistry, 2019-03, Vol.48 (10), p.3249-3262

2019

Link zum Volltext

Verfügbarkeit prüfen

Dual Imaging Gold Nanoplatforms for Targeted Radiotheranostics

Materials, 2020-01, Vol.13 (3), p.513

2020

Link zum Volltext

Verfügbarkeit prüfen

Mn(III) porphyrins as potential MRI contrast agents for diagnosis and MRI-guided therapy

Coordination chemistry reviews, 2021-10, Vol.445, p.214069, Article 214069

2021

Link zum Volltext

Verfügbarkeit prüfen

Metal-based redox-responsive MRI contrast agents

Coordination chemistry reviews, 2019-07, Vol.390, p.1-31

2019

Link zum Volltext

Verfügbarkeit prüfen

Response to Letter to the Editors: “Have we lost an essential link between coordination chemistry and medical applications?”

Coordination chemistry reviews, 2022-06, Vol.461, p.214494, Article 214494

2022

Link zum Volltext

Verfügbarkeit prüfen

Lanthanopolyoxometalate‐Silica Core/Shell Nanoparticles as Potential MRI Contrast Agents

European journal of inorganic chemistry, 2021-09, Vol.2021 (34), p.3458-3465

2021

Link zum Volltext

Verfügbarkeit prüfen

Development of a bioreactor system for cytotoxic evaluation of pharmacological compounds in living cells using NMR spectroscopy

Journal of pharmacological and toxicological methods, 2019-01, Vol.95, p.70-78

2019

Link zum Volltext

Verfügbarkeit prüfen

The quest for biocompatible phthalocyanines for molecular imaging: Photophysics, relaxometry and cytotoxicity studies

Journal of inorganic biochemistry, 2016-01, Vol.154, p.50-59

2016

Link zum Volltext

Verfügbarkeit prüfen

Multifunctionalization of cyanuric chloride for the stepwise synthesis of potential multimodal imaging chemical entities

Arabian journal of chemistry, 2020-01, Vol.13 (1), p.2517-2525

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

Diagnosis of tuberculosis in the wild boar (Sus scrofa): a comparison of methods applicable to hunter-harvested animals

QT/QTc Prolongation in Placebo-Treated Subjects: a PhRMA Collaborative Data Analysis

Alternative Analysis Methods for Time to Event Endpoints Under Nonproportional Hazards: A Comparative Analysis

Diversity and composition of cultivable gut bacteria in an endemic island bird and its mainland sister species

Antimicrobial susceptibility and oxymino-β-lactam resistance mechanisms in Salmonella enterica and Escherichia coli isolates from different animal sources

JAVELIN head and neck 100: A phase 3 trial of avelumab in combination with chemoradiotherapy (CRT) vs CRT for 1st-line treatment of locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)

Comparative Genotypic and Antimicrobial Susceptibility Analysis of Zoonotic Campylobacter Species Isolated from Broilers in a Nationwide Survey, Portugal

Ceritinib in advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK+) non-small cell lung cancer (NSCLC): Results of the ASCEND-1 trial

Ceritinib in Asian versus Caucasian patients (Pts) with advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK+) NSCLC: Subgroup analysis of the ASCEND-1 trial

BM-32 CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL

BM-32CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL

Apixabin with antiplatelet therapy after acute coronary syndrome

Investigating Drug-Induced QT and QTc Prolongation in the Clinic: A Review of Statistical Design and Analysis Considerations: Report from the Pharmaceutical Research and Manufacturers of America QT Statistics Expert Team

An adaptive randomized design with application to estimation

The doubly adaptive weighted differences design

A biocompatible redox MRI probe based on a Mn(ii)/Mn(iii) porphyrin

Dual Imaging Gold Nanoplatforms for Targeted Radiotheranostics

Mn(III) porphyrins as potential MRI contrast agents for diagnosis and MRI-guided therapy

Metal-based redox-responsive MRI contrast agents

Response to Letter to the Editors: “Have we lost an essential link between coordination chemistry and medical applications?”

Lanthanopolyoxometalate‐Silica Core/Shell Nanoparticles as Potential MRI Contrast Agents

Development of a bioreactor system for cytotoxic evaluation of pharmacological compounds in living cells using NMR spectroscopy

The quest for biocompatible phthalocyanines for molecular imaging: Photophysics, relaxometry and cytotoxicity studies

Multifunctionalization of cyanuric chloride for the stepwise synthesis of potential multimodal imaging chemical entities

Suchergebnisse filtern